Training | 2018.08.29
Long-Term Study Shows Endothelial Progenitor Cells Are Safe for Treating Stroke Patients
A new study recently published in STEM CELLS Translational Medicine demonstrates the long-term safety of laboratory-expanded endothelial progenitor cells for treating ischemic stroke. This could be good news for the 15 million people who, according to to the World Stroke Organization, suffer from this dangerous condition each year.
(PRWeb August 29, 2018)
Read the full story at https://www.prweb.com/releases/long_term_study_shows_endothelial_progenitor_cells_are_safe_for_treating_stroke_patients/prweb15721666.htm
For more information, please visit
https://www.prweb.com/releases/long_term[...]oke_patients/prweb15721666.htm
